Drug
K0706
K0706: highest development phase Phase 2, developed by Sun Pharma. 3 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Sun Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| K0706 NCT03655236 | Phase 2 | Early Parkinson Disease |
| K0706 NCT02970019 | Phase 1 | Parkinson Disease |
| K0706 NCT03445338 | Phase 1 | Healthy |
Latest
No recent events.
Follow K0706 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.